Late Amplatzer device displacement after percutaneous PDA embolization: case description.

Janiszewski, Adrian; Pasławska, Urszula; Pasławski, Robert; Cepiel, Alicja; Noszczyk-Nowak, Agnieszka

doi:10.21521/mw.5649

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The order of prevalence of these defects is related to the dog breed population in a particular geographical region. Publications in Poland have described single cases of CHD (6,7), prevalence of aortic stenosis (15), tricuspid dysplasia (17), and tetralogy of Fallot (16), and a description of treatment of pulmonic stenosis (19). A large-scale study of the number and types of congenital heart defects in Poland has not been published to date.…”

Section: Praca Oryginalnamentioning

confidence: 99%

Congenital heart defects in dogs: A retrospective study of 301 dogs

Garncarz¹,

Parzeniecka-Jaworska²,

Szaluś‐Jordanow³

2017

Medycyna Weterynaryjna

View full text Add to dashboard Cite

SummaryThe aim of the study was to assess the frequency of congenital heart defects in a population of dogs in Poland and to determine which breeds were affected by particular defects. A retrospective study of the medical records of cardiologically examined dogs revealed 301 cases of echocardiographically confirmed congenital heart defects. Dogs with congenital heart defects made up 2.7% of the dogs that underwent a cardiologic examination. The age at diagnosis ranged from 2 weeks to 190 months. Mixed breeds (33 dogs, 11%), Bull Terriers (31, 10%), Boxers (28, 9%), German Shepherds (17, 6%), Yorkshire Terriers (17, 6%), and French Bulldogs (16, 5%) were the most frequently affected breeds. Subaortic stenosis (120 cases, 33.9%), pulmonic stenosis (64, 18.1%), patent ductus arteriosus (59, 16.7%), mitral valve dysplasia (56, 15.8%), ventricular septal defect (24, 6.8%) and tricuspid valve dysplasia (17, 4.8%) were the most frequent congenital heart defects recognized in this study. Isolated congenital heart disease occurred in 258 dogs (86%), while multiple heart defects were noted in 43 dogs (14%). Most (60%) congenital heart defects were recognized in dogs older than 1 year. Early recognition of congenital heart defects is important for better patient care. Collecting information on the frequency of congenital heart defects in particular breeds will be useful in educating breeders and thus in improving the overall health of the breed.

show abstract

Section: Praca Oryginalnamentioning

confidence: 99%

Congenital heart defects in dogs: A retrospective study of 301 dogs

Garncarz¹,

Parzeniecka-Jaworska²,

Szaluś‐Jordanow³

2017

Medycyna Weterynaryjna

View full text Add to dashboard Cite

show abstract

“… 2 , 6 , 31 Postoperative device embolization is described rarely in dogs after PDA occlusion using Gianturco coils 6 , 16 , 42 as well as with ACDO 2 in the first 24 hours after intervention. Delayed embolization in the following days to weeks is described rarely in case reports in dogs with ACDO, 43 AVP‐II, 44 and AVP‐IV 36 and often associated with severe cardiorespiratory compromise. 43 , 44 …”

Section: Discussionmentioning

confidence: 99%

“…Delayed embolization in the following days to weeks is described rarely in case reports in dogs with ACDO, 43 AVP‐II, 44 and AVP‐IV 36 and often associated with severe cardiorespiratory compromise. 43 , 44 …”

Section: Discussionmentioning

confidence: 99%

Transvenous embolization of moderate to large patent ductus arteriosus in dogs using the Amplatzer vascular plug II

Hildebrandt

Stosic

Henrich

et al. 2021

Veterinary Internal Medicne

View full text Add to dashboard Cite

Background Catheter‐based occlusion of patent ductus arteriosus (PDA) can be performed using different devices. Transvenous embolization using the Amplatzer vascular plug II (AVP‐II) has been studied in humans, but it has not been described in dogs. Objective Evaluate the feasibility and success of transvenous embolization of PDA using the AVP‐II in dogs. Animals Nineteen client‐owned dogs with left‐to‐right shunting PDA, with minimal ductal diameter >2.5 mm. Methods Prospective observational study using AVP‐II with transvenous access for PDA closure in dogs. Results Angiography showed a conical ductus with a long (n = 17) or short (n = 2) ampulla. The minimal diameter of the duct was 4.34 ± 1.11 mm, and the maximal diameter of the ampulla was 13.18 ± 3.47 mm. Technical success was achieved in 18 of the 19 (94.7%) patients after the first intervention and in all 19 (100%) patients after the second intervention. Postrelease angiography documented complete occlusion of the PDA in 10 of 19 (52.6%) dogs. Mild flow acceleration or stenosis of the left pulmonary artery was found in 6 and 1 of the 17 analyzed cases, respectively, by Doppler examination. The closure rate 24 hours after intervention was 94.7% (18/19). The remaining dog had a moderate residual shunt, and delayed complete closure after 3 months led to a 100% closure rate. Conclusion and Clinical Importance The AVP‐II is a safe and effective device for transvenous embolization in dogs with moderate to large PDA.

show abstract

Late Amplatzer device displacement after percutaneous PDA embolization: case description.

Cited by 2 publications

References 13 publications

Congenital heart defects in dogs: A retrospective study of 301 dogs

Congenital heart defects in dogs: A retrospective study of 301 dogs

Transvenous embolization of moderate to large patent ductus arteriosus in dogs using the Amplatzer vascular plug II

Contact Info

Product

Resources

About